[1] |
张岩.血清胱抑素C与2型糖尿病慢性并发症关系的研究[D].长春: 吉林大学, 2016. |
[2] |
HORITA S, NAKAMURA M, SUZUKI M, et al.Selective Insulin Resistance in the Kidney[J].Biomed Res Int, 2016, 2016:5825170. |
[3] |
WANG Y, QUAGLIARINI F, GUSAROVA V, et al.Mice lacking ANGPTL8(Betatrophin) manifest disruptedtriglyceride metabolism without impaired glucose homeostasis[J].Proc Natl Acad Sci USA, 2013, 110(40):16109. |
[4] |
CHEN X, LU P, HE W, et al.Circulating betatrophinlevels are increased in patients with type 2 diabetes and associated withinsulin resistance[J].J Clin Endocrinol Metab, 2015, 100(1):E96. |
[5] |
YAMADA H, SAITO T, AOKI A, et al.Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes[J].Endocr J, 2015, 62(5):417. |
[6] |
YI P, PARK JS, MELTON DA.Betatrophin:a hormone that controls pancreaticbeta cell proliferation[J].Cell, 2013, 153:747. |
[7] |
EBERT T, KRALISCH S, HOFFMANN A, et al.Circulating angiopoietin-like protein 8 is independently associated withfasting plasma glucose and type 2 diabetes mellitus[J].J Clin Endocrinol Metab, 2014, 99(12):E2510. |
[8] |
TOKUMOTO S, HAMAMOTO Y, FUJIMOTO K, et al.Correlation of circulatingbetatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulationtests[J].Diabet Med, 2015, 32(5):653. |
[9] |
CHEN CC, SUSANTO H, CHUANG WH, et al.Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function[J].Cardiovasc Diabetol, 2016, 15:3. |
[10] |
汪琼, 金国玺, 于磊.血清胰岛素样生长因子-1-、胰岛素样生长因子结合蛋白-3与2型糖尿病肾病的关系[J].蚌埠医学院学报, 2016, 41(5):586. |
[11] |
HU H, SUN W, YU S, et al.Increased circulating levelsof betatrophin in newly diagnosed type 2 diabetic patients[J].Diabetes Care, 2014, 37(10):2718. |
[12] |
EROL O, ELLIDAČ HY, AYIK H, et al.Evaluation of circulating betatrophin levels in gestational diabetes mellitus[J].Gynecol Endocrinol, 2015, 31:652. |
[13] |
AGHADAVOD E, KHODADADI S, BARADARAN A, et al.Role of oxidative stress and inflammatory factors in diabetic kidney disease[J].Iranian J Kidney Dis, 2016, 10(6):337. |
[14] |
MIRANDA-DIAZ AG, PAZARIN-VILLASENOR L, YANOWSKY-ESCATELL FG, et al.Oxidative stress in diabetic nephropathy with early chronic kidney disease[J].J Diabetes Res, 2016, 2016:7047238. |
[15] |
EJARQUE M, BORLAUG M, VILARRASA N, et al.Angiopoietin-like protein8/betatrophin as a new determinant of type 2 diabetes remission afterbariatricsurgery[J].Transl Res, 2017, 5(7):34. |
[16] |
杨敏, 于菁, 马小羽, 等.初诊2型糖尿病病人不同尿白蛋白阶段血清betatrophin、脂联素及白细胞介素1β水平的相关性研究[J].中华内分泌代谢杂志, 2017, 33(2):116. |
[17] |
KRALISCH S, HOFFMANN A, KRATZSCH J, et al.The brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus[J].Diabetes Metab, 2017, 23(8):56. |
[18] |
AL-RAWASHDEH A, KASABRI V, BULATOVA N, et al.The correlation between plasma levels of oxytocin and betatrophin in non-diabetic and diabetic metabolic syndrome patients:a cross sectional study from Jordan[J].Diabetes Metab Syndr, 2017, 11(1):59. |
[19] |
ZHANG MH, FENG L, ZHU MM, et al.The anti-inflammation effect of moutan cortex on advanced glycation end products-induced rat mesangial cells dysfunction and high-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats[J].Ethnopharmacol, 2014, 151(1):591. |
[20] |
FENZL A, ITARIU BK, KOSI L, et al.Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals[J].Diabetologia, 2014, 57(6):1204. |
[21] |
ZHANG R, ABOU-SAMRA AB.Emerging roles of Lipasin as a critical lipid regulator[J].Biochem Biophys Res Commun, 2013, 432(3):401. |
[22] |
ZHANG R.Lipasin, a novel nutritionally-regulated liver-enriched factorthat regulates serum triglyceride levels[J].Biochem Biophys Res Commun, 2012, 424(4):786. |
[23] |
MAURER L, SCHWARZ F, FISCHER-ROSINSKY A, et al.Renal function is independently associated with circulating betatrophin[J].PLoS One, 2017, 12(3):e0173197. |